383930 — DT&CRO Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual income statement for DT&CRO Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	20,089	32,749	44,008	26,586	35,971
Cost of Revenue
Gross Profit	2,058	7,541	8,975	-6,715	-3,099
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	21,439	28,239	38,714	39,758	47,266
Operating Profit	-1,350	4,510	5,294	-13,171	-11,295
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-1,396	4,356	5,291	-17,307	-1,539
Provision for Income Taxes
Net Income After Taxes	-1,396	4,328	5,256	-16,636	-1,999
Net Income Before Extraordinary Items
Net Income	-1,396	4,328	5,256	-16,636	-1,999
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-1,396	4,328	5,256	-16,636	-1,999
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	26.4	374	513	-1,257	-155
Dividends per Share